Feng Xuan, Xue Feng, He Guihua, Huang Suiping, Ni Qing
Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, 225001, Jiangsu, People's Republic of China.
Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou, 225001, Jiangsu, People's Republic of China.
Onco Targets Ther. 2021 May 19;14:3297-3307. doi: 10.2147/OTT.S288442. eCollection 2021.
Banxia xiexin decoction (BXXX) is a classical Chinese herbal compound for the treatment of gastrointestinal diseases. Its ingredients are also considered helpful for cancer rehabilitation. Here, we will explore the regulatory mechanism of BXXX acting on PD-L1 in gastric cancer (GC).
GC samples and the general baseline data of the patients were collated. Immunohistochemical (IHC) detected the expression of programmed cell death-ligand 1(PD-L1), hypoxia-inducible factor-1 (HIF-1), epidermal growth factor receptor (EGFR), interferon-γ receptor (IFNGR) and Toll-like receptor 4 (TLR4). ELISA detected the expressions of EGF, IFNG and IL-6 in serum samples. Network tools were used to analyze the potential molecules of BXXX. In the cell experiment, CCK-8 detected the cell proliferation. Tunel detected the apoptosis. Western blot detected the expression of related proteins. In animal experiments, the tumor volume of GC-bearing mice was observed. Expression of EGF, IFNG and IL-6 in the serum of tumor-bearing GC mice were detected by ELISA. Western blot detected the expression of related proteins.
The expressions of PD-L1, HIF-1, EGFR, IFNGR and TLR4 in the tissues of GC patients were significantly increased, and the expressions of EGF, IFNG and IL-6 in serum were increased. The molecular results of the network tools showed that BXXX and its main components have a targeting effect on the key molecules of each pathway in the PD-L1 regulatory network. Cell experiments showed that BXXX can inhibit the expression of PD-L1, HIF-1, EGFR and TLR4, but has no significant effect on the expression of IFNGR, thus inhibiting the proliferation and promoting the apoptosis of GC cells. The results were consistent with the animal experiments on tumor-bearing gastric cancer mice.
BXXX inhibited the expression of PD-L1 through multi-target and multi-pathway regulation of major oncogenes in GC, thus effect cell proliferation and apoptosis.
半夏泻心汤是治疗胃肠道疾病的经典中药复方。其成分也被认为有助于癌症康复。在此,我们将探讨半夏泻心汤对胃癌(GC)中程序性死亡配体1(PD-L1)的调控机制。
整理GC样本及患者的一般基线数据。免疫组织化学(IHC)检测程序性细胞死亡配体1(PD-L1)、缺氧诱导因子-1(HIF-1)、表皮生长因子受体(EGFR)、干扰素-γ受体(IFNGR)和Toll样受体4(TLR4)的表达。酶联免疫吸附测定(ELISA)检测血清样本中表皮生长因子(EGF)、干扰素-γ(IFNG)和白细胞介素-6(IL-6)的表达。利用网络工具分析半夏泻心汤的潜在分子。在细胞实验中,细胞计数试剂盒-8(CCK-8)检测细胞增殖。TUNEL法检测细胞凋亡。蛋白质免疫印迹法检测相关蛋白的表达。在动物实验中,观察荷GC小鼠的肿瘤体积。ELISA检测荷瘤GC小鼠血清中EGF、IFNG和IL-6的表达。蛋白质免疫印迹法检测相关蛋白的表达。
GC患者组织中PD-L1、HIF-1、EGFR、IFNGR和TLR4的表达显著增加,血清中EGF、IFNG和IL-6的表达增加。网络工具的分子结果表明,半夏泻心汤及其主要成分对PD-L1调控网络中各途径的关键分子具有靶向作用。细胞实验表明,半夏泻心汤可抑制PD-L1、HIF-1、EGFR和TLR4的表达,但对IFNGR的表达无显著影响,从而抑制GC细胞的增殖并促进其凋亡。结果与荷瘤胃癌小鼠的动物实验一致。
半夏泻心汤通过多靶点、多途径调控GC中的主要癌基因,抑制PD-L1的表达,从而影响细胞增殖和凋亡。